Auto-Detection of Alzheimer's Disease Using Deep Convolutional Neural Networks

Lu Yue, Xiaoliang Gong, Kaibo Chen, Mingze Mao, Jie Li, A. Nandi, Maozhen Li
{"title":"Auto-Detection of Alzheimer's Disease Using Deep Convolutional Neural Networks","authors":"Lu Yue, Xiaoliang Gong, Kaibo Chen, Mingze Mao, Jie Li, A. Nandi, Maozhen Li","doi":"10.1109/FSKD.2018.8687207","DOIUrl":null,"url":null,"abstract":"Alzheimer's disease(AD) is a kind of progressive neurodegenerative disease. One who is diagnosed as an Alzheimer's disease patient may has many symptoms, such as deterioration of memory and language. Once those symptoms was noticed, they usually can survive 4 to 20 years. So far, Alzheimer's disease has become the sixth leading cause of death, and it has become a worldwide health and social challenge. Traditional methods of diagnosing AD and mild cognitive impairment(MCI), mostly depend on capturing features from variable modalities of brain image data. It is a big challenge to pick out the MCI from normal controller (NC) and AD, especially for those who are lacking experience. In this article, we employ deep convolutional neural network (DCNN) to extract the most useful features of the structural magnetic resonance imaging (MRI). Firstly, the structural MRls are pre-processed in a strict pipeline. Then, instead of parcellating regions of interest, we re-slice each volume, and put the resliced images into a DCNN directly. Finally, four stages of Alzheimer's are identified, and the average accuracy is 94.5% for NC versus LMCI, 96.9% for NC versus AD, 97.2% for LMCI and AD, 97.81 % for EMCI versus AD, 94.8% for LMCI versus EMCI. The results show that the DCNN outperforms existing methods.","PeriodicalId":235481,"journal":{"name":"2018 14th International Conference on Natural Computation, Fuzzy Systems and Knowledge Discovery (ICNC-FSKD)","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"34","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"2018 14th International Conference on Natural Computation, Fuzzy Systems and Knowledge Discovery (ICNC-FSKD)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/FSKD.2018.8687207","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 34

Abstract

Alzheimer's disease(AD) is a kind of progressive neurodegenerative disease. One who is diagnosed as an Alzheimer's disease patient may has many symptoms, such as deterioration of memory and language. Once those symptoms was noticed, they usually can survive 4 to 20 years. So far, Alzheimer's disease has become the sixth leading cause of death, and it has become a worldwide health and social challenge. Traditional methods of diagnosing AD and mild cognitive impairment(MCI), mostly depend on capturing features from variable modalities of brain image data. It is a big challenge to pick out the MCI from normal controller (NC) and AD, especially for those who are lacking experience. In this article, we employ deep convolutional neural network (DCNN) to extract the most useful features of the structural magnetic resonance imaging (MRI). Firstly, the structural MRls are pre-processed in a strict pipeline. Then, instead of parcellating regions of interest, we re-slice each volume, and put the resliced images into a DCNN directly. Finally, four stages of Alzheimer's are identified, and the average accuracy is 94.5% for NC versus LMCI, 96.9% for NC versus AD, 97.2% for LMCI and AD, 97.81 % for EMCI versus AD, 94.8% for LMCI versus EMCI. The results show that the DCNN outperforms existing methods.
利用深度卷积神经网络自动检测阿尔茨海默病
阿尔茨海默病(AD)是一种进行性神经退行性疾病。一个被诊断为阿尔茨海默病患者可能有许多症状,如记忆和语言退化。一旦这些症状被发现,他们通常可以存活4到20年。到目前为止,阿尔茨海默病已经成为第六大死亡原因,它已经成为一个全球性的健康和社会挑战。传统的诊断AD和轻度认知障碍(MCI)的方法主要依赖于从脑图像数据的可变模式中捕获特征。从普通控制器(NC)和AD中挑选MCI是一个很大的挑战,特别是对于那些缺乏经验的人来说。在本文中,我们使用深度卷积神经网络(DCNN)来提取结构磁共振成像(MRI)中最有用的特征。首先,在严格的流水线中对结构MRls进行预处理。然后,我们不再分割感兴趣的区域,而是重新切片每个体积,并将重新切片的图像直接放入DCNN中。最后,确定了阿尔茨海默氏症的四个阶段,NC与LMCI的平均准确率为94.5%,NC与AD的平均准确率为96.9%,LMCI和AD的平均准确率为97.2%,EMCI与AD的平均准确率为97.81%,LMCI与EMCI的平均准确率为94.8%。结果表明,该方法优于现有方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信